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Abstract  
We present the first case of human chorionic gonadotropin (hCG) induced recurrent ischemic 
priapism in a 3 years-old boy in the English literature. The patient underwent second right 
orchidopexy and hCG treatment (1500 IU twice a week for three weeks) was initiated the day 
after the operation. Twenty-three days after the last injection, he presented to our clinic with the 
complaint of painless erections. After the diagnosis of ischemic priapism, conservative 
management and oral diazepam therapy was initiated and the result was successful.  hCG therapy 
may rarely cause recurrent ischemic priapism in children.  
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Introduction  
Priapism is described as prolonged full or 
partial penile erection lasting more than 4 
hours unrelated to sexual stimulus [1]. It is a 
rare condition in children. Types of priapism 
are as follows: ischemic (low-flow or veno- 
 
occlusive), stuttering (intermittent or  
recurrent ischemic), and non-ischemic (high-
flow or arterial) [2]. Ischemic priapism is the 
most common type seen in children, mainly 
due to sickle–cell disease (SCD). On the 
other hand, androgen replacement therapy 
may cause ischemic and non-ischemic 
priapism. The exact mechanism of 
testosterone induced priapism is not clear. 
Mild increased frequency/duration of 
erections is a well-known side-effect of 
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testosterone [3]. Human chorionic 
gonadotropin (hCG) induce testicular 
descent by stimulating testosterone and/or 
dihydrotestosterone production and can be 
used in children with cryptorchidism [4]. To 
our knowledge, hCG induced recurrent 
ischemic priapism is not reported before in 
the English literature. Here we report a case 
of recurrent ischemic priapism in 3 years-old 
boy after hCG treatment for right 
cryptorchidism.  
 
Case Reports 
A 3 years-old boy with the complaint of 
semi-rigid, painless, and prolonged (>4 
hours) erection was presented to our clinic 
[Fig. 1].   
 
Fig. 1. Priapism episode at the presentation. 
 
The patient was underwent second right 
orchiopexy 45 days ago and hCG treatment 
(Pregnyl®, 1500 IU twice a week for three 
weeks) was initiated the day after the 
surgery. First priapism episode occurred 23 
days after the last hCG injection and 
repeated one more time. There was no 
history of perineal trauma, malignancy, SCD 
or use of other medications. Right testis was 
palpated at the outer ring of the inguinal 
canal and relatively hypoplastic when 
compared to left testis. Left testis was 
normal. At the time of presentation hormone 
levels and complete blood count results were 
as follows; FSH: 0,948 mIU/mL (range: 0,2-
3 mIU/mL), LH: 0,107 mIU/mL (range: 0,2-
5 mIU/mL), total testosterone: 2,00 ng/dL 
(range: 0,1-0,2 ng/dL), free testosterone: 
0,72 pg/mL (range: 0,15-0,6 pg/mL), 
prolactine: 9,63 ng/mL (range: 4,6-16,5 
ng/mL), white blood cell: 11.6 (range: 4-11 
K/uL), platelet count: 521 (range (150-420 
K/uL). Abdominal ultrasonography was 
normal. Penile duplex ultrasonography 
(PDU) demonstrated decreased flow velocity 
and increased resistive index (RI) of the 
cavernosal artery [Fig. 2].   
 
Fig. 2. Penile duplex ultrasonography 
examination during penile erection revealed 
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decreased flow velocity and increased resistive 
index (RI) values of the cavernous artery. Peak-
systolic velocity (PS): 9cm/s, end-diastolic 
velocity (ED): 0 cm/s and RI=1. We used a high-
end ultrasound machine (Logic 9, GE 
Healthcare, Milwaukee, WI, USA) with a 
multifrequency linear array transducer (5-13 
MHz).  
 
There was no arteriovenous fistula. These 
radiological findings suggested low flow 
(ischemic) priapism [5]. SCD and leukemia 
were excluded by normal hemoglobin 
electrophoresis and peripheral blood smear. 
We did not perform cavernosal blood 
aspiration. Diazepam therapy was initiated 
(0,8 mg/kg/day) and used for two weeks. 
Recurrent prolonged, painless nocturnal 
erections were occurred two times in 
consequent two nights after the initiation of 
diazepam therapy and then disappeared. No 
priapism episode occurred again. The patient 
was discharged to home after 2 weeks. 
Tertiary right orchidopexy was successfully 
performed 2 months after discharge. 
 
Discussion 
Priapism is an emergency condition that 
requires immediate diagnosis and 
appropriate treatment to prevent the 
development of corporal fibrosis and future 
erectile dysfunction (ED).  Ischemic 
priapism is a persistent, painful erection 
marked by rigidity of the corpora cavernosa 
and by little or no cavernous arterial inflow, 
resulting in corporal hypoxia and tissue 
ischemia, hypercapnia, and acidosis. It 
accounts for more than 95% of all priapism 
episodes. The most common cause of 
ischemic priapism in children is SCD. Other 
common causes are leukemia, trauma, 
idiopathic, and pharmacologically induced 
[2]. Nonischemic priapism is much rarer 
than ischemic priapism, etiology is largely 
attributed to trauma, and intervention is not 
urgent and often unnecessary. Pain is never 
as severe as in an ischemic priapism; the 
erection is not as rigid, and pulsation may be 
visible in the penis [6]. 
The most common pharmaceutical agents 
causing priapism include intracavernous and 
oral treatments for ED, psychotropic drugs, 
arterial vasodilators, and hormones like 
testosterone.  hCG induce testicular descent 
by increasing weight and vascularity of 
testis and also by stimulating testosterone 
and/or dihydrotestosterone production and 
can be used in children with cryptorchidism 
[4]. Acne, enlargement of penis and testes, 
growth of pubic hair, rapid increase in 
height, bloating, stomach and pelvic pain, 
decreased amount of urine are some of the 
side effects of hCG, which are associated 
with high testosterone levels. Although 
testosterone may cause ischemic and 
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nonischemic priapism, it is extremely rare 
despite the association between increased 
frequency and duration of erection and 
testosterone [2,7]. On the other hand, the 
mechanism of testosterone induced priapism 
is not clear. Intramuscular administration of 
testosterone leads to a supraphysiological 
increase in total serum testosterone, with 
peak levels being achieved within 48 hours 
and a return to baseline occurring at 
approximately 21 days. Therefore, there is a 
significant period during which high levels 
of circulating testosterone are present. It has 
been shown that supraphysiological levels of 
testosterone may predispose men to 
polycythemia and subsequent thrombosis as 
a result of stimulation of erythropoiesis. 
Also, an increase in local testosterone levels 
may result in an increased susceptibility to 
priapism [7]. On the other hand, androgens 
are key players in the physiology of 
nocturnal erections [3]. Men with low 
testosterone levels have lower nocturnal 
erection testosterone thresholds. In early 
puberty, gonadotropins are only released 
during rapid eye-movement sleep, which 
results in peak testosterone levels and 
nocturnal erections [8]. To our knowledge, 
hCG induced recurrent ischemic priapism in 
a healthy boy with cryptorchidism is not 
reported before in the English literature. 
There is only one article regarding hCG 
induced priapism in German literature [9]. In 
our case, we thought that supraphysiological 
levels of testosterone (testosterone level was 
tenfold higher than normal level) related 
nocturnal erections triggered recurrent 
ischemic priapism. Also, SCD and other risk 
factors for priapism were excluded. 
Although the symptom of painless erection 
was suggesting non-ischemic priapism, 
radiological findings confirmed recurrent 
ischemic priapism.  
 Analgesics, physical exercise, urination, a 
cold bath, and fluids can be used as 
conservative management in priapism. Many 
drugs can be used in recurrent ischemic 
priapism in children (Pseudoephedrine, 
Terbutaline, Baclofen etc.) [2]. On the other 
hand, no treatment of choice has been 
established due to the limited data with 
regard to recurrent ischemic priapism [10]. 
Benzodiazepines such as diazepam also can 
be used in the conservative management of 
ischemic or recurrent priapism [10]. 
Diazepam may be used short-term as muscle 
relaxants reducing the tone of skeletal 
muscle. In our case, we did not perform 
invasive therapy to avoid corporal fibrosis. 
Diazepam therapy was initiated (0.8 
mg/kg/day). After the initiation of diazepam 
therapy, recurrent priapism episodes 
disappeared in two days and never occurred 
again.  
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In conclusion, this is the first case of hCG 
induced recurrent ischemic priapism in a boy 
in the English literature. hCG treatment in 
boys may rarely cause recurrent ischemic 
priapism. Discontinuation of hCG and 
initiation of diazepam therapy may be 
adequate in hCG induced recurrent ischemic 
priapism in children. 
 
 
 
 
 
Acknowledgements 
The author(s) declare that they have no 
competing interests and financial support
 
 
References 
1. Broderick GA, Kadioglu A, Bivalacqua 
TJ, Ghanem H, Nehra A, Shamloul R. 
Priapism: pathogenesis, epidemiology, 
and management. J Sex Med. 2010; 7(1 
Pt 2): 476-500. 
2. Donaldson JF, Rees RW, Steinbrecher 
HA. Priapism in children: a 
comprehensive review and clinical 
guideline. J Pediatr Urol. 2014; 
10(1):11-24. 
3. Montorsi F, Oettel M. Testosterone and 
sleep-related erections: an overview. J 
Sex Med. 2005; 2(6):771-84.  
4. Kucharski P, Niedzielski J. Neoadjuvant 
human Chorionic Gonadotropin (hCG) 
therapy may improve the position of 
undescended testis: a preliminary report. 
Cent European J Urol. 2013; 66(2):224-
8.  
5. Halls JE, Patel DV, Walkden M, Patel U. 
Priapism: pathophysiology and the role  
 
 
 
of the radiologist. Br J Radiol. 2012; 
(85):79-85. 
6. Pryor J, Akkus E, Alter G, Jordan G, 
Lebret T, Levine L, et al. Priapism. J Sex 
Med. 2004; 1(1):116-20. 
7. Shergill IS, Pranesh N, Hamid R, Arya 
M, Anjum I. Testosterone induced 
priapism in Kallmann's syndrome. J 
Urol. 2003; 169(3):1089. 
8. Donaldson JF, Davis N, Davies JH, Rees 
RW, Steinbrecher HA. Priapism in 
teenage boys following depot 
testosterone. J Pediatr Endocrinol Metab. 
2012; 25(11-12):1173-6. 
9. Asbach HW, Kösters S, Thomas P, 
Mühlenberg R, Melekos M. Priapism in 
childhood (author's transl). Monatsschr 
Kinderheilkd. 1981; 129(10):585-8. 
10. Molina ER, Rodriguez FE, Lledo GE, 
Tabares JJ, Husillos AA, Hernandez FC. 
Stuttering priapism: case report and  
 
Coguplugil et al / Ped Urol Case Rep 2016;3(4):99-104                                                                                          104  
     http://www.pediatricurologycasereports.com  
      bibliographic review. Arch Esp Urol.  
      2010; 63(7):559-62.   
Access this article online 
http://pediatricurologycasereports.com      
            Quick Response Code 
        
 
Pediatric Urology Case Reports is an open access journal. Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (see http://creativecommons.org/ and http://creativecommons.org/licenses/by/4.0/). 
